XML 88 R78.htm IDEA: XBRL DOCUMENT v3.25.4
Derivative Instruments and Hedging Activities - Schedule of Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($)
$ in Millions
3 Months Ended
Jan. 30, 2026
Jan. 31, 2025
Derivative Instruments, Gain (Loss) [Line Items]    
Net sales $ 1,036.3 $ 995.0
Cost of Product and Service Sold (699.8) (659.4)
Cash flow hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of (loss) gain reclassified from AOCL into earnings (2.3) (1.4)
Net sales | Cash flow hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
Net sales 1,036.3 995.0
Net sales | Cash flow hedging | Forward currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of (loss) gain reclassified from AOCL into earnings (2.3) 0.2
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value 1.1 0.2
Cost of sales | Cash flow hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
Cost of Product and Service Sold (699.8) (659.4)
Cost of sales | Cash flow hedging | Forward currency contracts    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of (loss) gain reclassified from AOCL into earnings 0.0 (1.6)
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 0.4 $ 0.9